Citation

Doong KS, Gaccione DM, Brown TA. Am. J. Pharm Benefits 2016; 8(6): 227-229.

Copyright

(Copyright © 2016, Managed Care and Healthcare Communications)

DOI

unavailable

PMID

unavailable

Abstract

Electronic Prescription Drug Monitoring Programs (PDMPs) were created in the effort to reduce opioid abuse. However, the full potential impact of these programs has not been realized because enrollment for all healthcare providers is not mandatory. Community pharmacists can help improve quality of care and play a more active role in the patient care process through the use of PDMPs. Limitations to implementing PDMP use in community pharmacy practice include administrative burden, technical issues, and prescriber concerns. This article addresses these concerns and emphasizes the importance of community pharmacists' involvement in decreasing prescription drug abuse through the use of PDMPs. However, their impact is limited without mandatory involvement from other healthcare providers.

Language: en